Veterinary Regenerative Medicine Market

Market Overview

The global veterinary regenerative medicine market size, valued at USD 388 Million in 2025, is projected to reach USD 437 Million in 2026 and USD 1,189 Million by 2035, representing a CAGR of 11.8% during the forecast period.

Market Report: Key Takeaways

• In terms of product, stem cell therapies is securing 53% of the market share driven by the widespread adoption of these therapies to treat wounds, damages tissues and chronic conditions.
• Based on application area, orthopedic segment is securing nearly 42% of the market share due to the increasing adoption of stem cell therapies and platelet-rich plasma for the treatment of age-associated musculoskeletal degeneration and osteoarthritis in animals.
• With regards to end user, the veterinary hospitals / clinics segment holds the highest share (over 60%) of the market.

• North America is presently dominating the market, accounting for nearly 45% of the market share. This is due to the growing pet ownership and expanding research on stem cell therapies.

Market Introduction

Regenerative medicine refers to the use of stem cells and platelet-rich plasma and cells to repair and regenerate damaged tissues and organs. The concept of regenerative medicine has recently gain popularity in veterinary field, driven by the rising pet ownership and growing awareness about zoonotic diseases. Similar to humans, animals also experience age-related muscle degeneration, osteoarthritis and chronic conditions. As pet owners are seeking their pet as a family member, they are investing heavily in drug-free solutions to manage chronic conditions of pets, which is likely to be a key growth factor for this market.

The ongoing demand for advanced therapeutic solutions has caught the attention of market players to develop regenerative medicine and ready-to-use therapies to improve pet and livestock animals health. However, the primary focus on the industrial players will be on restoration of lost tissue function which got damage due to orthopedic injuries, wounds, and joint diseases in livestock and companion animals.

It is worth mentioning here that several market players, such as Zoetis (US), and Gallant (US) are increasingly leveraging partnerships and investments to strengthen their research and development activities on stem cell therapies for pet. For instance, in July 2025, Gallant (US) has successfully raised USD 18 million in a Series B funding round to support the development and commercialization of its off-the-shelf stem cell therapy for animals. Owing to the increasing initiatives, we believe that veterinary regenerative medicine market will grow steadily in the future.

Market Trends

• Expanding Exosome Therapy in Veterinary Applications: Beyond orthopedic and wound healing applications, the bone marrow-derived stem cells in animals are widely used in neurological application. It is important to highlight here that several researches are currently being conducted across the globe evaluating the use of stem cell therapies in nerve repair, neuroregeneration, spinal cord injury and degenerative brain disease in animals. This expanding usage of stem cell therapies across different therapeutic applications is likely to offer enormous opportunities to industrial players for innovation.
• Rise in Clinical Trials: Currently, several market players are initiating clinical trials for determining the efficacy of veterinary regenerative medicine for equine tendonitis, and canine osteoarthritis. These accelerated clinical trials for the regulatory submission and development of advanced veterinary regenerative medicines are likely to cater the attention of industrial players in the future.

Industry Experts on Veterinary Regenerative Medicine Market

Veterinary regenerative medicine industry have a promising future, driven by the ongoing research on stem cell therapies for pet and rising approval from the USFDA.

Dr Rebecca Windsor (Director of Veterinary Affairs at Gallant, US) stated that, "Seeing the impact of stem cell therapy has been extraordinary—watching pets who might otherwise have faced euthanasia or lifelong medical management truly improve," "Now that these therapies are becoming ready-to-use, standardized, and available on demand, they are poised to become part of mainstream veterinary care. As Gallant advances through the USFDA drug approval process to bring the first ready-to-use stem cell therapy into everyday practice, our goal is to ensure practitioners feel confident and prepared for the regenerative medicine era.”

Market Segmentation Insights

Market Share by Type of Animal: Which Animal Types are Seeing the Fastest Uptake Of Regenerative Therapies?

• The global market is segmented across different type of animal, such as small animals and large animals. According to the veterinary regenerative medicine market report, the small animals segment holds nearly 55% of the overall market share. This highest share is likely to be the result of rising adoption of small animals, such as pets, dogs and cats as companion animals.
• It is important to highlight here that large animal segment will continue to grow at a higher CAGR in the future. This lucrative growth is due to the growing incidence of muscle injuries in large animals, such as horse. Additionally, the high willingness to spend on large companion animal health. Notably, the key players are emphasizing the development of platelet-rich plasma and stem cell therapies for sound treatment, and osteoarthritis treatment in livestock, which further fuel its demand in the future.

Market Share by Type of Product: Will the Demand for Stem Cell Therapies for Pet Increase in the Future?

• The global market is further categorized across different type of product, such as stem cell therapy (autologous, and allogeneic), biological therapy (platelet-rich plasma (PRP), and growth factor), and tissue engineering. According to the veterinary regenerative medicine market forecast, the stem cell therapy segment is dominating the market, accounting for 53% of the overall revenue share. This dominance is due to the growing acceptance of stem cell therapies for animal treatment and accelerating approval of regenerative medicine for animals by the USFDA.
• It is important to highlight here that the platelet-rich plasma segment is likely to grow in the future at a higher CAGR. This is generally driven by the rising use of platelet-rich plasma to treat osteoarthritis and musculoskeletal injuries in animals. In addition, the platelet-rich plasma is cost-effective and stimulate the tissue regeneration for wound healing, which further accelerate its adoption.

Market Share by Application Area: What Clinical Applications are Most Common in Veterinary Regenerative Medicine Market?

• Based on the application area, the global market is segmented into orthopedics, trauma / wound care, and other application areas. According to our analysis, the orthopedic segment is dominating the market by holding nearly 42% of the veterinary regenerative medicine market share. The dominance stems from the increasing usage of stem cell therapies for the treatment of orthopedic conditions, such as osteoarthritis, and ligament tearing in animals.
• Notably, the trauma and wound care segment is likely to grow at the fastest CAGR in the future. This is primarily due to the fact that tissue engineering and stem cell therapies are widely adopted as the advanced wound care solution in animals.

Market Share by End User: Which End User is Dominating the Market?

• Based on the end user, the global market is distributed across veterinary hospitals & clinics, and veterinary research institute. According to the veterinary regenerative medicine market analysis, the veterinary hospitals & clinics segment is dominating, accounting for more than 60% of the overall revenue share. Several factors, such as availability of advanced healthcare infrastructure, stem cell therapies products and professional veterinarian along with daily care services in hospital settings are the key reasons for the highest share.
• In the long run, veterinary research institute segment is likely to register higher CAGR during the forecast period. This is likely to be the result of rising focus on stem cell therapies research to treat wide range of chronic conditions in animals.

Regional Insights

North America Accounts for the Largest Share

According to our projection, North America currently occupies the highest share (nearly 45%) of the veterinary regenerative medicine market growth. This can be attributed to the increasing pet ownership, high demand for advanced treatments to mitigate the growing concern of chronic conditions and favorable regulatory guidelines are fueling the market growth in this region.

Asia-Pacific is the Rising Hubspot

In Asia-Pacific, the market for veterinary regenerative medicine is expected to witness highest CAGR during the forecast period. This lucrative growth stems from the rising government initiatives to support animal health, such as development of veterinary vaccines and advanced stem cell therapies.

Veterinary Regenerative Medicine Market: Report Deliverables

Market Segmentation Insights

Veterinary Regenerative Medicine Market, by Type of Animal

• Small Animals
• Large Animals

Veterinary Regenerative Medicine Market, by Type of Product

• Stem Cell therapy
• Autologous
• Allogeneic
• Biological Therapy
• Platelet-Rich Plasma (PRP)
• Growth factor
• Tissue Engineering

Veterinary Regenerative Medicine Market, by Application Area

• Orthopedics
• Trauma / Wound Care
• Other Application Areas

Veterinary Regenerative Medicine Market, by End User

• Veterinary Hospitals & Clinics
• Veterinary Research Institute

Veterinary Regenerative Medicine Market, by Geographical Regions

• Noth America
• US
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• New Zealand
• Rest of the Asia-Pacific
• Middle East & Africa
• Egypt
• Iran
• Iraq
• Israel
• Saudi Arabia
• South Africa
• United Arab Emirates
• Latin America
• Argentina
• Brazil

Frequently Asked Questions